Citations
Showing 10 of 108081 citations.
Der(6)t(1;6)(q21–23;p21.3): The most specific chromosomal translocation in myelofibrosis with myeloid metaplasia
Mahaffey, Victor, Spurbeck, Jack L., DeWald, Goron W, Tefferi, Ayalew , Dingli, David
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6548-6548
N0234: Phase II study of erlotinib (OSI-774) plus gemcitabine as first-or second-line therapy for metastatic breast cancer (MBC)
Graham, David L. , Hobday, Timothy J. , Rousey, Steven R., Nair, Sreekumar, Soori, Gamini S. , Sabagh, Tarek, Perez, Edith A. , Hillman, David W.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 644-644
Breast cancer patients have better outcomes than prostate cancer patients for palliation of painful bone metastases: Results of RTOG 97–14
Hartsell, William F. , Winter, K. De, Scarantino, Charles W., Ivker, R., Roach, Mack, Demas, William F., Movsas, Benjamin , Petersen, Ivy A. , Konski, André , Bruner, Deborah Watkins , Suh, John H.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6073-6073
Relationships among quality of life and survival in anemic patients with advanced cancer undergoing chemotherapy
Sloan, Jeff A. , Schaefer, Paul, Novotny, Paul J. , Silberstein, Peter T., Beardon, J. D., Allred, Jacob B., Mailliard, J A, Loprinzi, Charles L. , Witzig, Thomas E.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6027-6027
SWOG/Intergroup 9623: A phase III comparison of intensive sequential chemotherapy to high dose chemotherapy and autologous hematopoietic progenitor cell support (AHPCS) for primary breast cancer in women with ≥4 involved axillary lymph nodes
Bearman, SI, Green, S., Barlow, William, Hudis, Clifford A. , Hortobágyi, G. N., Livingston, R., Martino, Silvana, Green, S., Gralow, Julie R. , Wolff, Antonio C. , Ingle, James N. , Livingston, R. B.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 572-572
Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma
Bernold, D. M., Foote, Robert L. , Link, Michael J., Moynihan, Timothy J. , Buckner, Jan C. , Khurana, Vikas , Giannini, Caterina
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 5534-5534
Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial
Brufsky, Adam , Harker, W G, Carroll, Robert R., Tan-Chiu, Elizabeth, Seidler, C. W., Lacerna, Leo V., Thomas, E. W. Prosser, Perez, Edith A. , Beck, J. Thaddeus , Thomas, E., Brufsky, Adam M
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 533-533
Phase II evaluation of dacarbazine (D), mitomycin-C (M), doxorubicin (A) and cisplatin (P) (DMAP) plus sargramostim (GM-CSF) in the treatment of advanced, persistent, or recurrent leiomyosarcoma of the uterus: A Gynecologic Oncology Group (GOG) study
Long, Harry J., Blessing, John A., Sorosky, Joel I.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 5077-5077
Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013) in patients with transfusion-dependent (TD) myelodysplastic syndrome (MDS) and chromosome 5q31.1 deletion: Results of the multicenter MDS-003 Study
Dewald, G, Bennett, Jeffrey, Giagounadis, A., Raza, Azra , Feldman, E., Powell, Benjamin, Greenberg, Peter L. , Zeldis, Jerome B. , List, Alan F. , Knight, Robert
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 5-5
Salvage brachytherapy and short-term androgen deprivation therapy for locally recurrent prostate cancer after external beam irradiation
Wong, W. , Buskirk, S.J., Karin, Putu Ayu Emmy Savitri , Schild, Steven E.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4788-4788